Nurse Practitioner Awareness Training
Tuesday, May 10, 2022
Drug Enforcement Administration (DEA) will be hosting an one-day virtual training session entitled, DEA Diversion Nurse Practitioner Awareness Training. This educational activity is designed only for nurse practitioners who are certified to prescribe controlled substances. The virtual session will be held from 1:00 p.m. to 5:00 p.m. (EST), 12:00 pm to 4:00 (CST), 11:00 am to 3:00 pm (MST), and 10:00 am to 2:00 pm (PST). Participants must register to attend the session. The session will have a maximum capacity of 3,000 participants and will close once registration capacity is reached. It is recommended you register as early as possible.
Upon completion of this activity, participants will receive CE credits and should be better able to:
- Understand the state of the Opioid Crisis today and identify current drug trends
- Learn where to locate DEA regulations and other resources
- Recognize drug diversion and learn about healthcare fraud schemes
- Understand prescribing and applying DEA record keeping regulations
This activity is approved for 3.70 contact hour(s) of continuing education(which includes 0.00 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22025371. This activity was planned in accordance with AANP Accreditation Standards and Policies.
There is no registration fee for this session. This is the same training session that was held in March and April 2022. Do not register if you attended the previous sessions.
A Zoom link will be provided immediately upon confirmation of your registration.
Any questions regarding this conference may be directed to VDAT@dea.gov.